Abstract
P05-13 Refining the high potency category rules to enhance the accuracy of exposure-based waiving arguments within a Next Generation Risk Assessment for skin sensitisation
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have